Biontech Se opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Biontech Se

Patent Number:
Title:
Modified Messenger Rna Comprising Functional Rna Elements
Applicant:
Opposition Date:
Feb 23, 2024
Patent Number:
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Applicant:
Opposition Date:
Dec 6, 2023
Patent Number:
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Opposition Date:
Nov 30, 2023
Patent Number:
Title:
Methods And Means For Enhancing Rna Production
Applicant:
Opposition Date:
Oct 4, 2023
Patent Number:
Title:
Polynucleotides Encoding Interleukin-12 (Il12) And Uses Thereof
Applicant:
Opposition Date:
Aug 2, 2023
Patent Number:
Title:
Infectious Disease Vaccines
Applicant:
Opposition Date:
Jul 10, 2023
Patent Number:
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Applicant:
Opposition Date:
Apr 27, 2023
Patent Number:
Title:
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
Opposition Date:
Dec 2, 2022
Patent Number:
Title:
Lyophilization Of Rna
Applicant:
Opposition Date:
Sep 29, 2022
Patent Number:
Title:
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof
Applicant:
Opposition Date:
Sep 23, 2022

Latest patents of Biontech Se opposed by its competitors

Patent:
Grant Date:
Apr 26, 2023
Title:
Individualized Vaccines For Cancer
Oppositions:
1
Patent:
Grant Date:
Oct 27, 2021
Title:
Methods For Providing Single-Stranded Rna
Oppositions:
1
Patent:
Grant Date:
Sep 8, 2021
Title:
Individualized Vaccines For Cancer
Oppositions:
1
Patent:
Grant Date:
Jul 10, 2019
Title:
Individualized Vaccines For Cancer
Oppositions:
3

Competitors of Biontech Se

CUREVAC AG

MODERNATX, INC.

CUREVAC SE

Want to track Biontech Se?

Feel free to send us a message here and we will get back to you